Betthera selected as Health Economics partner in EU Horizon projects
Betthera recently participated to several EU Horizon proposals as a Health Economics and / or Regulatory partner. This included proposals in neuromodulation of pain, in gastroenterology diagnostics by smart capsules, rare diseases, life style and mental health, chronic wounds, stroke, heart failure and orthopaedic implants. And some these projects were already selected for funding and started! Betthera is already involved in assessment of the current diagnostic or intervention processes and in pre-assessment of the potentially new solutions. Two examples of running projects are below:
eCAP – TOWARDS UNIVERSAL ACCESS TO DIGESTIVE DISEASE DIAGNOSTICS
The eCAP consortium will develop a smart multi-sensing capsule, implanted by minimally invasive techniques, that enables gastrointestinal (GI) physiology monitoring for a controlled period of time. Using ubiquitous smartphone communication standards and cloud computing, real-time patient experience data will be collected through an interactive user-friendly application. Patient-empowered disease management will be supported by accurate interpretation of the data by physicians, aided by Artificial Intelligence. “More accurate, cost-effective, patient-friendly testing for acid reflux is an increasingly urgent need today that the current solutions out on the market do not meet. I think the exciting thing is that this particular group of partners is uniquely suited to getting together to solve the problem of GI diseases affecting people worldwide”, explains Lee Swanström, Project Coordinator from the IHU Strasbourg. “As we began discussions, we had great ideas for expanding the initial proof of concept, even beyond GERD testing, so the project has enormous potential.
PAINLESS – PAIN RELIEF IN PALLIATIVE CARE OF CANCER USING HOME-BASED NEUROMODULATION AND PREDICTIVE BIOMARKERS
PAINLESS addresses a core component of pain relief, by using an innovative, evidence-based approach. The objective is to adapt and implement a novel, cost-effective, home-based intervention based on neuromodulation to reduce pain and improve quality of life of cancer patients with chronic pain. On the assumption that treatment of chronic pain can benefit from research on the brain mechanisms of pain, we will first attempt to improve our understanding of the role of central pain modulation. The project will be organized in 3 studies to assess the feasibility an efficacy of at-home delivery of transcranial low intensity electric stimulation (tES) for the palliative care of cancer patients suffering from pain PAINLESS will develop a customized web portal to share knowledge and to improve management of the patients; perform techno-economic analyses and Health Technology Assessment of the solution; analyze the possibilities of implementation in different European healthcare systems and results exploitation; and undertake an ambitious dissemination and communication strategy. We will also propose a wide range of measures to ensure compliance with the highest ethical standars.
Get in touch for more information on our Horizon projects and our Health economics activities.